|
|
TAN 06,401 J01C GSK
|
Augmentin
|
Amoxicillin ( as amoxicillin trihydrate) 875 mg,Clavulanic acid (as potassium clavulanate) 125 mg
|
SmithKline Beecham Pharmaceuticals
|
Registered/Compliant
|
Details →
|
|
|
TZ 15 H 0396
|
Augmentin ES
|
Amoxicillin Trihydrate equivalent to Amoxicillin 600 mg,Potassium Clavulanate Equivalent to Clavulanic Acid 42.9 mg
|
GLAXOWELLCOME PRODUCTION
|
Registered/Compliant
|
Details →
|
|
|
TAN 00,522 J01C AUR
|
Aurocef 250
|
Cefalexin Monohydrate equivalent to Cefalexin 250 mg
|
-
|
Registered/Compliant
|
Details →
|
|
|
TAN 07,437 C01E AUR
|
Auroliza 10
|
Lisinopril 10 mg
|
-
|
Registered/Compliant
|
Details →
|
|
|
TAN 07,438 C01E AUR
|
Auroliza 5
|
Lisinopril Dihydrate equivalent to Lisinopril 5 mg
|
-
|
Registered/Compliant
|
Details →
|
|
|
TZ13H230
|
Auropodox 200
|
Cefpodoxime Proxetil 200 mg,Lactose Monohydrate mg,Maize starch mg
|
-
|
Registered/Compliant
|
Details →
|
|
|
TZ10H121
|
Aurotaz P 4.5
|
Piperacillin Sodium equivalent to Piperacillin 4000 mg,Tazobactam Sodium equivalent to Tazobactam 500 mg
|
Aurobindo Pharma Limited (Unit-XII)
|
Registered/Compliant
|
Details →
|
|
|
TAN 07,130 J01D AUR
|
Auroxetil 250
|
Cefuroxime Axetil 250 mg
|
Aurobindo Pharma limited
|
Registered/Compliant
|
Details →
|
|
|
TZ10H113
|
Auroxetil 500
|
Cefuroxime Axetil 500 mg
|
Aurobindo Pharma Limited (Unit VI)
|
Registered/Compliant
|
Details →
|
|
|
TAN 00,4581 J01D AUR
|
Auroxone
|
Ceftriaxone 1000 mg
|
Aurobindo Pharma Limited, Unit-VI
|
Registered/Compliant
|
Details →
|
|
|
TAN 20 HM 0393
|
Austfluzol
|
Fluconazole 150 mg
|
BDA HEALTHCARE PRIVATE LIMITED
|
Registered/Compliant
|
Details →
|
|
|
TZ 17 H 0094
|
Auxtocef 250
|
Cefuroxime Axetil equivalent to Cefuroxime 250 mg
|
INNOVA CAPTAB LIMITED
|
Registered/Compliant
|
Details →
|
|
|
TZ 16 H 0213
|
Auxtocef 500
|
Cefuroxime Axetil 500 mg
|
INNOVA CAPTAB LTD
|
Registered/Compliant
|
Details →
|
|
|
TZ 16 H 0251
|
Auxtocef-125
|
Cefuroxime Axetil 125 mg/5mL
|
Innova Captab Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 26 HM 0042
|
Avamys Nasal Spray
|
Benzalkonium Chloride Solution 0.0165 mg/6 mL,Disodium Edetate 0.00825 mg/6 mL,Dispersible Cellulose 0.825 mg/6 mL,Fluticasone Furoate (micronised) 27.5 mcg/actuation,Glucose Anhydrous 2.750 mg/6 mL,Polysorbate-80 0.01375 mg/6 mL,Purified Water. 50 micro litre
|
Glaxo Wellcome S.A
|
Registered/Compliant
|
Details →
|
|
|
TZ11H004
|
Avamys Nasal Spray
|
Benzalkonium Chloride Solution w/v,Disodium Edetate w/v,Dispersible Cellulose w/v,Fluticasone Furoate (micronised) 27.5 mcg/actuation,Glucose Anhydrous w/v,Polysorbate 80 w/v,Purified Water MU/0.5 mL
|
Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations)
|
Registered/Compliant
|
Details →
|
|
|
TAN 22 HM 0483
|
Avanep
|
Nepafenac 0.1 % w/v
|
ATCO LABORATORIES
|
Registered/Compliant
|
Details →
|
|
|
TAN 06,089 B04A MIC
|
Avas 20
|
Atorvastatin Calcium equivalent to Atorvastatin 20 mg
|
Micro Labs Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 06,090 B04A MIC
|
Avas-10
|
Atorvastatin Calcium equivalent to Atorvastatin 10 mg
|
Micro Labs Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 09,014 V03A FLR
|
Avastin
|
Bevacizumab 100 TCID
|
F. Hoffmann-La Roche Ltd
|
Registered/Compliant
|
Details →
|